Scholars reflect on the continuing impact of the No Surprises Act.

A unanimous Supreme Court instructed the Fifth Circuit to reconsider the harmless error rule for agency action.

The Supreme Court weighs public safety concerns surrounding ghost guns in recent Second Amendment decision.

The Supreme Court’s recent unanimous decision on FDA’s drug-approval authority is utterly unremarkable.

The Supreme Court validates political control over public health decisions.

Your source of news, analysis, and opinion on regulatory law and policy sponsored by the Penn Program on Regulation at the University of Pennsylvania ...